Robot-assisted surgery in gynaecology.

CONCLUSIONS: Evidence on the effectiveness and safety of RAS compared with CLS for non-malignant disease (hysterectomy and sacrocolpopexy) is of low certainty but suggests that surgical complication rates might be comparable. Evidence on the effectiveness and safety of RAS compared with CLS or open surgery for malignant disease is more uncertain because survival data are lacking. RAS is an operator-dependent expensive technology; therefore evaluating the safety of this technology independently will present challenges.
PMID: 30985921 [PubMed - as supplied by publisher]

Source: Cochrane Database of Systematic Reviews - April 14, 2019 Category: General Medicine Authors: Lawrie TA, Liu H, Lu D, Dowswell T, Song H, Wang L, Shi G Tags: Cochrane Database Syst Rev Source Type: research